NCT06899750 E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control
| NCT ID | NCT06899750 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rush University Medical Center |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-02-10 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-02-10 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare a multidisciplinary clinical hypertension and social needs intervention to enhanced standard of care for hypertension management in primary care clinics with regards to hypertension control outcomes.
Eligibility Criteria
Inclusion Criteria: * Adults 18 years or older * African American and/or Latinx * Uncontrolled stage 2 hypertension, BP \>/= 140/90 * Patient is following with Rush primary care provider in eligible Rush primary care clinics * Patient has a smart phone (Android or iOS) * Patient has an email Exclusion Criteria: * Organ transplant recipient * On dialysis * Patient is already participating in another remote hypertension monitoring program * Patient is not interested in participating in the program * Patient has already participated in the E3 Hypertension program or the E3 Diabetes program
Contact & Investigator
Kristen Pallok, MD
PRINCIPAL INVESTIGATOR
Rush University Medical Center
Frequently Asked Questions
Who can join the NCT06899750 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06899750 currently recruiting?
Yes, NCT06899750 is actively recruiting participants. Contact the research team at Kristen_N_Pallok@rush.edu for enrollment information.
Where is the NCT06899750 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06899750 clinical trial?
NCT06899750 is sponsored by Rush University Medical Center. The principal investigator is Kristen Pallok, MD at Rush University Medical Center. The trial plans to enroll 200 participants.